MO

Moogene Medi Co., Ltd.

Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.

322970 | KO

Overview

Corporate Details

ISIN(s):
KR7322970005
LEI:
Country:
South Korea
Address:
경기도 하남시 미사강변중앙로7번안길 25씨동 10층(풍산동,유-테크밸리씨타워), 하남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Moogene Medi Co., Ltd. is a biotechnology company specializing in nano-medicine and the development of advanced drug delivery systems. The company focuses on its Lipid Nanoparticle (LNP) carrier system platform to create safer and more effective methods for transporting various therapeutic agents, such as genes, chemicals, and proteins. Moogene Medi aims to address incurable and severe diseases by developing novel therapeutics based on optimized LNPs tailored to each drug's characteristics. The company provides end-to-end support, from research and development to clinical study manufacturing in its aseptic, GMP-grade facility, also offering assay services for its developed nano-carrier systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Regulatory News Service
임상시험단계진입ㆍ종료(자율공시)
Korean 8.9 KB
2025-06-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 14.7 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 9.9 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 277.8 KB
2025-03-12 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 83.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.4 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.0 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.4 KB
2025-01-06 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-11-25 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-11-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-10-02 00:00
Regulatory News Service
기타주요경영사항(자율공시)
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all Moogene Medi Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Moogene Medi Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Moogene Medi Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Scilex Holding Co Logo
Develops and commercializes non-opioid products for acute and chronic pain management.
United States of America
SCLX
Scinai Immunotherapeutics Ltd. Logo
Dual-model biopharma: developing NanoAbs for I&I and offering CDMO services.
United States of America
SCNI
SciSparc Ltd. Logo
Developing cannabinoid-based therapies for central nervous system (CNS) disorders.
United States of America
SPRC
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
South Korea
298060
scPharmaceuticals Inc. Logo
Commercializes subcutaneous drug-device therapies for at-home cardiorenal care.
United States of America
SCPH
SCYNEXIS INC Logo
Developing novel anti-fungal therapies for difficult-to-treat, drug-resistant infections.
United States of America
SCYX
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel
SEMG
SEEGENE, INC. Logo
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea
096530
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan
4548
SELLAS Life Sciences Group, Inc. Logo
Late-stage biopharma developing novel immunotherapies for a broad range of cancers.
United States of America
SLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.